News | FFR Technologies | November 08, 2017

FAVOR II Studies Examine Accuracy of Quantitative Flow Ratio FFR-Angiography

FAVOR II China and FAVOR II Europe-Japan trials find sensitivity and specificity of QFR higher than traditional FFR

FAVOR II Studies Examine Diagnostic Accuracy of Quantitative Flow Ratio, FFR-Angio.

November 8, 2017 — Investigators in the FAVOR II China and FAVOR II Europe-Japan studies recently presented their results at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual conference, Oct. 29-Nov. 2, in Denver.

The FAVOR II China trial evaluated the diagnostic accuracy of quantitative flow ratio (QFR), a novel angiography-based method for deriving fractional flow reserve (FFR) without pressure wire or induction of hyperemia, in diagnosing hemodynamically-significant coronary stenosis as defined by FFR. Between June and July 2017, 308 patients were enrolled. Patient-level and vessel-level diagnostic accuracy of QFR were 92.4 percent (95 percent CI: 88.9-95.1 percent) and 92.7 percent (95 percent CI: 89.3-95.3 percent), both significantly higher than the prespecified target value (P<0.001). Sensitivity and specificity in identifying hemodynamically-significant stenosis were significantly higher for QFR than QCA.

“FAVOR II China showed that QFR has high feasibility and accuracy in identifying hemodynamically-significant coronary stenosis,” said Bo Xu, MBBS, director, catheterization laboratories at Fu Wai Hospital in Beijing, China. "It also demonstrates the clinical utility of QFR for use in diagnostic catheterization laboratories. QFR has the potential to improve angiography-based identification of functionally-significant stenosis during coronary angiography.”

FAVOR II Europe-Japan was a prospective observational, investigator-initiated study performed at 11 hospitals in Europe and Japan from March 2017 to October 2017 with a primary endpoint of sensitivity and specificity of QFR compared to two-dimensional QCA (2D-QCA) with FFR as reference standard. The study found that QFR had higher sensitivity (88 percent vs. 46 percent, P<0.001) and specificity (88 percent vs. 77 percent, P<0.001) compared to 2D-QCA. Key secondary endpoints of feasibility of QFR (defined as the fraction of vessels with successful FFR measurements where in-procedure QFR is computed) was 97 percent (N=373) and time to QFR was 4.8 minutes (IQR: 3.5-6.0) compared to 7 minutes for FFR (IQR: 5.0-10.0), P<0.001.

“QFR showed superior sensitivity and specificity for detection of functional significant lesions in comparison with 2D-QCA using FFR as reference standard,” said Jelmer Westra, MS, research fellow at Aarhus University Hospital in Aarhus N, Denmark. “In addition, in-procedure QFR computation was feasible and was computed within the time of standard FFR measurements. Still, randomized trials are needed to determine if a QFR-based diagnostic strategy provides non-inferior clinical outcomes compared to pressure wire based strategies.”

The FAVOR II Europe Japan study was funded by Aarhus University Hospital, Skejby and participating institutions. The QFR solution was provided for free during the study period. The FAVOR II CHINA trial was funded by Pulse medical imaging technology (Shanghai) Co., Ltd, the National Key Research and Development Program of China, and the Natural Science Foundation of China.

For more information: www.tctconference.com

 

Related Content

TCT 2017 Late-breaking Clinical Trial Presentations

 

Reference:

1. Bo Xu, Shengxian Tu, Shubin Qiao, et al. “Angiography-Based Quantitative Flow Ratio for Online Assessment of Coronary Stenosis: FAVOR II China Study.” JACC. DOI: 10.1016/j.jacc.2017.10.035.

Related Content

Canon Medical Launches Alphenix Encore Plus Program
News | Angiography | October 09, 2019
In the complex and fast-paced world of healthcare, customers face the challenge of staying up-to-date with the most...
The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology

The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology. Image courtesy of Siemens Healthineers.

Technology | Angiography | September 17, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of angiography systems...
Jackson Memorial Hospital Holds Ribbon-cutting for New Cardiac Catheterization Labs
News | Angiography | August 21, 2019
Jackson Memorial Hospital in Miami celebrated the opening of two newly renovated cardiac catheterization suites during...
Mentice and Siemens Healthineers Integrate VIST Virtual Patient With Artis Icono Angiography System
Technology | Angiography | June 24, 2019
Siemens Healthineers and Mentice AB announced the collaboration to fully integrate Mentice’s VIST Virtual Patient into...
Medis QAngio XA 3D Receives FDA 510k Clearance
Technology | Angiography | June 04, 2019
Medis Medical Imaging Systems B.V. has received clearance from the U.S. Food and Drug Administration for its QAangio XA...
iSchemaView Launches RAPID Angio
Technology | Angiography | March 01, 2019
iSchemaView announced the release of RAPID Angio, a complete neuroimaging solution for the angiography suite that...
Videos | Angiography | February 08, 2019
This is an example of an arterial venous malformation (AVM) in the brain imaged on a ...
Canon Medical Debuts Alphenix 4-D CT at RSNA 2018
Technology | Angiography | February 06, 2019
Canon Medical Systems USA Inc. recently introduced a new angiography configuration featuring its Alphenix Sky + C-arm...
Canon Medical Systems Launches Alphenix Interventional Imaging Line
Technology | Angiography | February 04, 2019
Canon Medical Systems USA recently introduced its next generation of interventional systems – the Alphenix platform....
An example of multimodality image fusion with live angiography to enhance soft-tissue visualization during complex procedures. This example is from Siemen's new TrueFusion software released in 2018. Advances in angiography imaging.

An example of multimodality image fusion with live angiography to enhance soft-tissue visualization during complex procedures. This example is from Siemen's new TrueFusion software released in 2018. 

Feature | Angiography | January 28, 2019 | Dave Fornell, Editor
There are a few recent trends in X-ray...
Overlay Init